Matches in Nanopublications for { ?s ?p "[The aim of this study was to evaluate the response and resistance of cases to chronic myeloid leukemia (CML) therapy with tyrosine kinase (TK) inhibitors (imatinib mesylate) and to search for mutations in the breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) kinase domain prior to and during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The aim of this study was to evaluate the response and resistance of cases to chronic myeloid leukemia (CML) therapy with tyrosine kinase (TK) inhibitors (imatinib mesylate) and to search for mutations in the breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) kinase domain prior to and during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP170806.RAEI9tDXUhx_Rx5FciZ6O_Yh8QV-kESjw68NVUfLXvVxs130_assertion description "[The aim of this study was to evaluate the response and resistance of cases to chronic myeloid leukemia (CML) therapy with tyrosine kinase (TK) inhibitors (imatinib mesylate) and to search for mutations in the breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) kinase domain prior to and during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170806.RAEI9tDXUhx_Rx5FciZ6O_Yh8QV-kESjw68NVUfLXvVxs130_provenance.
- NP675154.RA1VP4Mr9hnL_1q3KHXdHeT5KEiGFZ3DWbbh52x0B82tc130_assertion description "[The aim of this study was to evaluate the response and resistance of cases to chronic myeloid leukemia (CML) therapy with tyrosine kinase (TK) inhibitors (imatinib mesylate) and to search for mutations in the breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) kinase domain prior to and during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP675154.RA1VP4Mr9hnL_1q3KHXdHeT5KEiGFZ3DWbbh52x0B82tc130_provenance.
- NP778144.RASlmcO1feBNdCzZYFNbb12rTaBeU7uO9cMgeaXODrhOU130_assertion description "[The aim of this study was to evaluate the response and resistance of cases to chronic myeloid leukemia (CML) therapy with tyrosine kinase (TK) inhibitors (imatinib mesylate) and to search for mutations in the breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) kinase domain prior to and during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778144.RASlmcO1feBNdCzZYFNbb12rTaBeU7uO9cMgeaXODrhOU130_provenance.
- NP786874.RAEQcPmdE8whVhXkp61oq-sUMCm6ifEfONNTVo7DXIvAw130_assertion description "[The aim of this study was to evaluate the response and resistance of cases to chronic myeloid leukemia (CML) therapy with tyrosine kinase (TK) inhibitors (imatinib mesylate) and to search for mutations in the breakpoint cluster region (BCR)-Abelson murine leukemia (ABL) kinase domain prior to and during therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786874.RAEQcPmdE8whVhXkp61oq-sUMCm6ifEfONNTVo7DXIvAw130_provenance.